88 related articles for article (PubMed ID: 2843240)
1. Occurrence of the 15-hydroxy derivative of dihomogammalinolenic acid in human platelets and its biological effect.
Guichardant M; Naltachayan-Durbin S; Lagarde M
Biochim Biophys Acta; 1988 Sep; 962(1):149-54. PubMed ID: 2843240
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product.
Lagarde M; Burtin M; Rigaud M; Sprecher H; Dechavanne M; Renaud S
FEBS Lett; 1985 Feb; 181(1):53-6. PubMed ID: 3918886
[TBL] [Abstract][Full Text] [Related]
3. Dihomogammalinolenic acid, but not eicosapentaenoic acid, activates washed human platelets.
Siess W; Siegel FL; Lapetina EG
Biochim Biophys Acta; 1984 Sep; 801(2):265-76. PubMed ID: 6089912
[TBL] [Abstract][Full Text] [Related]
4. Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids.
Lagarde M; Croset M; Guichardant M; Dechavanne M
Adv Exp Med Biol; 1985; 192():327-35. PubMed ID: 3938923
[No Abstract] [Full Text] [Related]
5. Physiological relevance of the formation of 15-hydroxy derivative from dihomogammalinolenic acid in human platelets.
Lagarde M; Naltchayan-Durbin S; Guichardant M; Mazet M; Dechavanne M
Prog Clin Biol Res; 1987; 242():71-5. PubMed ID: 3671395
[No Abstract] [Full Text] [Related]
6. Isolation of a new lipoxygenase metabolite of arachidonic acid, 8. 11, 12-trihydroxy-5,9,14-eicosatrienoic acid from human platelets.
Bryant RW; Bailey JM
Prostaglandins; 1979 Jan; 17(1):9-18. PubMed ID: 108769
[TBL] [Abstract][Full Text] [Related]
7. Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid.
Lagarde M; Guichardant M; Dechavanne M
Prog Lipid Res; 1981; 20():439-43. PubMed ID: 6804973
[No Abstract] [Full Text] [Related]
8. Enhancement of eicosaenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid.
Croset M; Lagarde M
Lipids; 1985 Nov; 20(11):743-50. PubMed ID: 3934487
[TBL] [Abstract][Full Text] [Related]
9. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation.
Lagarde M; Burtin M; Sprecher H; Dechavanne M; Renaud S
Lipids; 1983 Apr; 18(4):291-4. PubMed ID: 6408333
[TBL] [Abstract][Full Text] [Related]
10. Interactions between prostaglandin precursors during their oxygenation by human platelets.
Boukhchache D; Lagarde M
Biochim Biophys Acta; 1982 Nov; 713(2):386-92. PubMed ID: 6295499
[TBL] [Abstract][Full Text] [Related]
11. Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation.
Chen P; Véricel E; Lagarde M; Guichardant M
FASEB J; 2011 Jan; 25(1):382-8. PubMed ID: 20833872
[TBL] [Abstract][Full Text] [Related]
12. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
13. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
[TBL] [Abstract][Full Text] [Related]
14. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
15. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
16. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
17. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
18. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
19. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
[TBL] [Abstract][Full Text] [Related]
20. Omega 6-oxygenation of 6, 9, 12-octadecatrienoic acid in human platelets.
Hamberg M
Biochem Biophys Res Commun; 1983 Dec; 117(2):593-600. PubMed ID: 6318765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
